Circulation · 2004 · 75 citations · 11 references
MedicineBiochemistryCardiologyClinical BiochemistryEnzymologyMolecular DiagnosticsAcute Coronary SyndromesCardiac BiomarkersElectrocardiographyIschemic Heart DiseaseAcute Myocardial Infarction DiagnosisBiochemical Marker AssaysBiochemical Marker AssessmentCardiac Enzyme MarkersCreatine Kinase-mbElectrocardiographic ChangesMyocardial Ischemia MarkersSerum Biomarkers
BACKGROUND: The delayed release of serum cardiac markers such as creatine kinase isoenzyme MB and equivocal early electrocardiographic changes have hampered a diagnosis of acute myocardial infarction (AMI) in the early phase after its onset. Therefore, a reliable serum biochemical marker for the diagnosis of AMI in the very early phase is desirable. METHODS AND RESULTS: Serum samples were collected from the patients with AMI, unstable angina pectoris, stable angina pectoris, and other diseases. Levels of serum deoxyribonuclease I (DNase I) activity in the patients were determined. An abrupt elevation of serum DNase I activity was observed within approximately 3 hours of the onset of symptoms in patients with AMI, with significantly higher activity levels (21.7+/-5.10 U/L) in this group compared with the other groups with unstable angina pectoris (10.4+/-4.41 U/L), angina pectoris (10.8+/-3.70 U/L), and other diseases (9.22+/-4.16 U/L). Levels of the DNase I activity in serum then exhibited a marked time-dependent decline within 12 hours and had returned to basal levels within 24 hours. CONCLUSIONS: We suggest that serum DNase I activity could be used as a new diagnostic marker for the early detection of AMI.
11
Elliott M. Antman, Jean‐Pierre Bassand, Werner Klein et al. · Journal of the American College of Cardiology · 2000 · 4.8K citations
Reperfusion injury induces apoptosis in rabbit cardiomyocytes.
Roberta A. Gottlieb, Katharine O. Burleson, Robert A. Kloner et al. · Journal of Clinical Investigation · 1994 · 1.4K citations · Full text